SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 25.26 Million USD | -28.29% |
| 2022 | 27.18 Million USD | 10.56% |
| 2021 | 24.59 Million USD | 19.13% |
| 2020 | 20.64 Million USD | -12.01% |
| 2019 | 23.46 Million USD | -22.35% |
| 2018 | 30.21 Million USD | 54.21% |
| 2017 | 19.59 Million USD | -7.01% |
| 2016 | 21.06 Million USD | 50.25% |
| 2015 | 14.02 Million USD | -37.01% |
| 2014 | 22.26 Million USD | 39.67% |
| 2013 | 15.94 Million USD | 11.43% |
| 2012 | 14.3 Million USD | -46.98% |
| 2011 | 26.98 Million USD | -24.12% |
| 2010 | 35.56 Million USD | 3.47% |
| 2009 | 34.36 Million USD | 8.2% |
| 2008 | 31.76 Million USD | -2.42% |
| 2007 | 32.55 Million USD | -0.47% |
| 2006 | 32.7 Million USD | -26.75% |
| 2005 | 44.64 Million USD | -0.01% |
| 2004 | 44.65 Million USD | -4.31% |
| 2003 | 46.65 Million USD | 1.98% |
| 2002 | 45.75 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 6.54 Million USD | 4.89% |
| 2024 Q2 | 6.54 Million USD | 0.0% |
| 2023 Q1 | 6.38 Million USD | -47.78% |
| 2023 Q3 | 6.24 Million USD | -50.65% |
| 2023 Q2 | 12.64 Million USD | 97.98% |
| 2023 Q4 | 6.24 Million USD | 0.0% |
| 2023 FY | 19.49 Million USD | -28.29% |
| 2022 Q2 | 14.82 Million USD | 99.18% |
| 2022 Q3 | 6.15 Million USD | -58.52% |
| 2022 FY | 27.18 Million USD | 10.56% |
| 2022 Q4 | 12.23 Million USD | 98.91% |
| 2022 Q1 | 7.44 Million USD | 8.7% |
| 2021 FY | 24.59 Million USD | 19.13% |
| 2021 Q2 | 5.44 Million USD | 0.0% |
| 2021 Q1 | 5.44 Million USD | -49.97% |
| 2021 Q3 | 6.84 Million USD | 25.71% |
| 2021 Q4 | 6.84 Million USD | 0.0% |
| 2020 Q2 | 9.89 Million USD | 101.11% |
| 2020 Q3 | 5.4 Million USD | -45.43% |
| 2020 FY | 20.64 Million USD | -12.01% |
| 2020 Q4 | 10.88 Million USD | 101.63% |
| 2020 Q1 | 4.92 Million USD | -53.36% |
| 2019 Q2 | 12.98 Million USD | 100.28% |
| 2019 Q1 | 6.48 Million USD | -41.46% |
| 2019 Q3 | 5.24 Million USD | -59.57% |
| 2019 FY | 23.46 Million USD | -22.35% |
| 2019 Q4 | 10.55 Million USD | 101.01% |
| 2018 Q4 | 11.07 Million USD | 99.27% |
| 2018 Q2 | 19.02 Million USD | 99.21% |
| 2018 Q1 | 9.55 Million USD | 79.88% |
| 2018 FY | 30.21 Million USD | 54.21% |
| 2018 Q3 | 5.55 Million USD | -70.79% |
| 2017 Q1 | 4.48 Million USD | -2.75% |
| 2017 FY | 19.59 Million USD | -7.01% |
| 2017 Q4 | 5.3 Million USD | 0.0% |
| 2017 Q3 | 5.3 Million USD | 18.33% |
| 2017 Q2 | 4.48 Million USD | 0.0% |
| 2016 Q3 | 4.61 Million USD | 14.52% |
| 2016 Q1 | 4.02 Million USD | -2.8% |
| 2016 Q2 | 4.02 Million USD | 0.0% |
| 2016 FY | 21.06 Million USD | 50.25% |
| 2016 Q4 | 4.61 Million USD | 0.0% |
| 2015 FY | 14.02 Million USD | -37.01% |
| 2015 Q4 | 4.14 Million USD | 0.0% |
| 2015 Q3 | 4.14 Million USD | -26.25% |
| 2015 Q2 | 5.62 Million USD | 0.0% |
| 2015 Q1 | 5.62 Million USD | 13.74% |
| 2014 FY | 22.26 Million USD | 39.67% |
| 2014 Q1 | 5.97 Million USD | 35.82% |
| 2014 Q2 | 5.76 Million USD | -3.58% |
| 2014 Q3 | 5.57 Million USD | -3.23% |
| 2014 Q4 | 4.94 Million USD | -11.44% |
| 2013 FY | 15.94 Million USD | 11.43% |
| 2013 Q4 | 4.4 Million USD | 10.85% |
| 2013 Q3 | 3.97 Million USD | 1.98% |
| 2013 Q2 | 3.89 Million USD | 6.02% |
| 2013 Q1 | 3.67 Million USD | 86.54% |
| 2012 Q3 | 3.97 Million USD | 7.09% |
| 2012 FY | 14.3 Million USD | -46.98% |
| 2012 Q4 | 1.96 Million USD | -50.47% |
| 2012 Q1 | 4.18 Million USD | -23.64% |
| 2012 Q2 | 3.71 Million USD | -11.24% |
| 2011 FY | 26.98 Million USD | -24.12% |
| 2011 Q4 | 5.47 Million USD | -13.95% |
| 2011 Q3 | 6.36 Million USD | -16.12% |
| 2011 Q1 | 7.55 Million USD | -21.05% |
| 2011 Q2 | 7.58 Million USD | 0.48% |
| 2010 Q1 | 8.7 Million USD | -9.4% |
| 2010 Q4 | 9.56 Million USD | 9.16% |
| 2010 Q3 | 8.76 Million USD | 2.71% |
| 2010 FY | 35.56 Million USD | 3.47% |
| 2010 Q2 | 8.53 Million USD | -1.93% |
| 2009 Q4 | 9.6 Million USD | 6.35% |
| 2009 FY | 34.36 Million USD | 8.2% |
| 2009 Q3 | 9.03 Million USD | 11.5% |
| 2009 Q2 | 8.09 Million USD | 6.05% |
| 2009 Q1 | 7.63 Million USD | 0.0% |
| 2008 Q2 | 7.76 Million USD | 0.0% |
| 2008 FY | 31.76 Million USD | -2.42% |
| 2007 FY | 32.55 Million USD | -0.47% |
| 2006 FY | 32.7 Million USD | -26.75% |
| 2005 FY | 44.64 Million USD | -0.01% |
| 2004 FY | 44.65 Million USD | -4.31% |
| 2003 FY | 46.65 Million USD | 1.98% |
| 2002 FY | 45.75 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accolade, Inc. | 192.06 Million USD | 86.847% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -42142.475% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 98.238% |
| CareCloud, Inc. | 46.24 Million USD | 45.372% |
| CareMax, Inc. | 13.9 Million USD | -81.721% |
| Definitive Healthcare Corp. | 203.93 Million USD | 87.613% |
| Health Catalyst, Inc. | 131.83 Million USD | 80.839% |
| iCoreConnect Inc. | 6.12 Million USD | -312.597% |
| Inovalon Holdings, Inc. | 499.7 Million USD | 94.945% |
| Omnicell, Inc. | 499.92 Million USD | 94.947% |
| Progyny, Inc. | 238.79 Million USD | 89.422% |
| R1 RCM Inc. | 484.5 Million USD | 94.786% |
| Schrödinger, Inc. | 140.69 Million USD | 82.045% |
| Simulations Plus, Inc. | 43.15 Million USD | 41.459% |
| Streamline Health Solutions, Inc. | 11.54 Million USD | -118.843% |
| SCWorx Corp. | 1.26 Million USD | -1890.5% |
| Sharecare, Inc. | 129.49 Million USD | 80.493% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -42142.475% |
| SOPHiA GENETICS SA | 42.91 Million USD | 41.134% |
| TruBridge, Inc. | 163.56 Million USD | 84.556% |
| Nutex Health, Inc. | 34.77 Million USD | 27.357% |
| Renalytix Plc | 156 Thousand USD | -16092.949% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 99.681% |
| Aclarion, Inc. | -324.00 USD | 7796704.938% |
| Forian Inc. | 15 Million USD | -68.358% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | 58.33% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 96.303% |
| HealthEquity, Inc. | 622.63 Million USD | 95.943% |
| 10x Genomics, Inc. | 409.31 Million USD | 93.828% |
| Zhongchao Inc. | 8.51 Million USD | -196.763% |
| HealthStream, Inc. | 184.04 Million USD | 86.274% |
| Augmedix, Inc. | 21.52 Million USD | -17.351% |
| MSP Recovery, Inc. | 5.56 Million USD | -354.335% |
| Spok Holdings, Inc. | 112.2 Million USD | 77.487% |
| Privia Health Group, Inc. | 161.5 Million USD | 84.359% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -2899.852% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 98.238% |
| Sharecare, Inc. | 129.49 Million USD | 80.493% |
| Premier, Inc. | 840.73 Million USD | 96.995% |
| Certara, Inc. | 213.31 Million USD | 88.158% |
| GeneDx Holdings Corp. | 60.62 Million USD | 58.33% |
| Ontrak, Inc. | 8.8 Million USD | -187.057% |
| CareCloud, Inc. | 46.24 Million USD | 45.372% |
| OneMedNet Corporation | -127.9 Thousand USD | 19850.586% |
| HeartBeam, Inc. | - USD | -Infinity% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -2899.852% |
| CareCloud, Inc. | 46.24 Million USD | 45.372% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -5754.216% |
| CareMax, Inc. | 13.9 Million USD | -81.721% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -272.746% |
| National Research Corporation | 86.66 Million USD | 70.852% |
| Aclarion, Inc. | -324.00 USD | 7796704.938% |
| OptimizeRx Corporation | 42.89 Million USD | 41.116% |